文献速递心血管腹部CT

无症状成人肝脂肪变性者的冠状动脉CT血管成像预后价值

Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
PubMed 文献 · Radiology · 2021-09-21

该前瞻性队列研究纳入接受CCTA及腹部平扫CT的无症状成人,按腹部CT分为肝脂肪变性组与无肝脂肪变性组,中位随访7.2年。结果显示,在存在冠状动脉疾病(CAD-RADS 1-5)时,肝脂肪变性组MACE风险更高;而无CAD(CAD-RADS 0)者两组预后均极佳。

要点

  • CAD-RADS 0的无症状肝脂肪变性者8.8年无事件生存率约99%,预后良好。
  • CAD-RADS 1-2或3-5时,肝脂肪变性者MACE风险显著高于无肝脂肪变性者。
  • 阅片时发现肝脂肪变性可提示CAD患者预后更差,需加强风险分层。

关键影像表现/征象

  • 肝脂肪变性组1013例中96例(10%)发生MACE,无肝脂肪变性组1940例中80例(4%)发生MACE。

临床应用与阅片要点

  • CCTA报告CAD-RADS分级时,可结合腹部CT提示的肝脂肪变性评估长期预后风险。
  • CAD-RADS 0且肝脂肪变性者预后良好,可避免过度干预。
  • CAD-RADS≥1合并肝脂肪变性者应视为高危,建议更积极的风险管理和随访。

局限性

  • 研究为单中心前瞻性队列,结论外推需谨慎。
  • 肝脂肪变性仅基于腹部平扫CT定性评估,未做定量分级。
  • 随访期间治疗变化可能影响MACE发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The long-term prognostic value of coronary CT angiography (CCTA) in asymptomatic adults with hepatic steatosis (HS) remains unknown. Purpose To evaluate the long-term prognostic value of CCTA in asymptomatic adults with HS. Materials and Methods Between January 2009 and December 2013, consecutive asymptomatic adults who underwent CCTA evaluation and unenhanced abdominal CT were prospectively enrolled. All participants were divided into two groups-with HS and without HS according to abdominal CT results. The primary end point was major adverse cardiovascular events (MACEs), defined as cardiac death, stroke, myocardial infarction, and angina requiring hospitalization. Multivariable Cox regression analysis and Kaplan-Meier analysis were used to compare survival rates. Results One thousand thirteen participants with HS and 1940 participants without HS who completed the follow-up were included (mean age, 66 years ± 10 [standard deviation] [range, 29-90 years]; 1940 men). During a median of 7.2 years of follow-up (interquartile range, 6.3-8.1), MACEs were observed in 96 of 1013 participants with HS (10%), whereas 80 of 1940 participants without HS (4%) had MACEs. In participants with a Coronary Artery Disease Reporting and Data System (CAD-RADS) category of 0, both participants with and without HS had a similar 8.8-year event-free survival rate (99.2% event-free survival rate in participants with HS vs 99.0% event-free survival rate in participants without HS, P = .77). As for participants with CAD-RADS categories 1 or 2 or 3-5, the 8.8-year event-free survival rate was lower in participants with HS than in those without HS (70.6% vs 85.2%, P < .001; 51.4% vs 71.7%, P = .03, respectively). The risk of MACEs was higher for participants with HS than for those without HS in CAD-RADS categories 1 and 2 (adjusted hazard ratio = 2.3; 95% CI: 1.4, 3.9; P < .001) and CAD-RADS categories 3-5 (adjusted HR = 2.1; 95% CI: 1.2, 3.6; P = .006) but not in the setting of CAD-RADS category 0 (adjusted HR = 5.1; 95% CI: 0.1, 398; P = .47). Conclusion Asymptomatic participants with hepatic steatosis (HS) had a worse prognosis than those without HS in the presence of coronary artery disease (CAD) at coronary CT angiography, whereas participants with HS and without CAD might have excellent clinical outcomes during a median follow-up of 7.2 years. © RSNA, 2021 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Yu MM, Tang XL, Jin H, et al. Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis. Radiology. 2021. PMID: 34546127. doi:10.1148/radiol.2021210355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。